Inje University Ilsan Paik Hospital — Goyang-si, Gyeonggi-do

Public research footprint of Inje University Ilsan Paik Hospital, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Migraine · Acute Non-cardioembolic Ischemic Stroke · Non-diabetic Chronic Kidney Disease · Ischemic Heart Disease

Recently updated registry entries

NCT06016842 — A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis (Recruiting)
NCT05702034 — A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk… (Active Not Recruiting)
NCT05953480 — A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Inje University Ilsan Paik Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.